Key facts
- Notable investors include Fosun Health Capital, Shanghai Yinglian Health Industry Equity Investment, Shenzhen Bangqin Venture Capital Fund Management, Xingkong Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Hailiang Medicine
- ·The full record, as it builds
Funding rounds
No funding rounds for Hailiang Medicine are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hailiang Medicine
Developer of pharmaceutical products for healthcare and life sciences applications.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2021
- Ownership
- Privately Held (backing)
Hailiang Medicine doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hailiang Medicine shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hailiang Medicine in its N-PORT filings yet. We sweep new filings monthly.